Pfizer Limited has announced the scheduling of its 75th Annual General Meeting (AGM), with the Board of Directors approving the date at their meeting held on May 12, 2026. The intimation was filed with BSE Limited and the National Stock Exchange of India Ltd. pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

AGM Details

The 75th AGM is set to be held on Tuesday, July 28, 2026, and will be conducted through Video-Conferencing (VC) or Other Audio-Visual Means (OAVM). The virtual format is in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India.

The key details of the upcoming AGM are summarised below:

Regulatory Compliance

The intimation was submitted to both BSE Limited and the National Stock Exchange of India Ltd. in line with the company's disclosure obligations. The filing was signed by Prajeet Nair, Director – Corporate Services & Company Secretary, on May 12, 2026.

Pfizer Limited has informed stock exchanges of the appointment of M/s. Kishore Bhatia & Associates as its Cost Auditors for the financial year ending March 31, 2027. The decision was taken by the Board of Directors, acting on the recommendation of the Audit Committee, at their meeting held on May 12, 2026. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment Details

The key details of the appointment, as disclosed in Annexure A filed with the exchanges, are summarised below:

The remuneration payable to M/s. Kishore Bhatia & Associates shall be placed before the shareholders for ratification at the ensuing Annual General Meeting.

Profile of the Appointed Firm

M/s. Kishore Bhatia & Associates is a firm of Practicing Cost Accountants based in Mumbai, offering a wide spectrum of services to its clientele. The firm has handled various assignments in costing, including:

• Cost audits and certifications
• Setting up costing systems
• Cost consultancy
• Costing-based turnaround strategies
• Internal audit, stock and assets verification, and industry studies

The firm has conducted Cost Audits for clients across diverse industries, including Pharmaceuticals, Engineering, Chemicals, Insecticides, Construction, Real Estate, Steel, Infrastructure, Telecommunications, Plastics & Polymers, Petroleum, FMCG, Medical Devices, Ports, Roads, Paints, and Energy. The firm comprises highly qualified Partners supported by an experienced professional team.

Regulatory Compliance

The filing was made in accordance with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The disclosure was signed by Prajeet Nair, Director – Corporate Services & Company Secretary of Pfizer Limited, on May 12, 2026.